 "Indoco Remedies buys Micro Labs' manufacturing facility in Baddi")
The Mumbai-headquartered pharmaceutical company Indoco Remedies Ltd has acquired the manufacturing facility located at Baddi, Himachal Pradesh, of Micro Labs Ltd, a Bangalore-based company.
The facility is spread over an area of 18,000 sq m, out of which 11,000 sq m is the built-up area. It produces 4.3 billion tablets and 50 million capsules per annum.
The acquired facility is close to Indoco’s existing manufacturing plant in Baddi making it another manufacturing hub for the company’s solid dosages business in the regulated markets.
With this acquisition, Indoco will now have six facilities for finished dosages and three for active pharmaceutical ingredients (APIs). Out of these, 3 facilities for finished dosages (including sterile plant) and 2 facilities for API manufacturing are US FDA approved.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%